{"id":45491,"date":"2022-06-24T18:01:29","date_gmt":"2022-06-24T16:01:29","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/"},"modified":"2022-06-24T18:01:29","modified_gmt":"2022-06-24T16:01:29","slug":"geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/","title":{"rendered":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5583499\/geographic-atrophy-drugs-in-development-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sj96pd&amp;utm_campaign=1718572+-+Geographic+Atrophy+Drugs+in+Development+Pipeline+Guide+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report provides comprehensive information on the therapeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.\n<\/p>\n<p>\nThe report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development and features dormant and discontinued projects.\n<\/p>\n<p>\nThe report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nThe pipeline guide provides a snapshot of the global therapeutic landscape of Geographic Atrophy\n<\/li>\n<li>\nThe pipeline guide reviews pipeline therapeutics for Geographic Atrophy by companies and universities\/research institutes based on information derived from company and industry-specific sources\n<\/li>\n<li>\nThe pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages\n<\/li>\n<li>\nThe pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&amp;D brief, MoA &amp; other developmental activities\n<\/li>\n<li>\nThe pipeline guide reviews key companies involved in Geographic Atrophy therapeutics and enlists all their major and minor projects\n<\/li>\n<li>\nThe pipeline guide evaluates Geographic Atrophy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type\n<\/li>\n<li>\nThe pipeline guide encapsulates all the dormant and discontinued pipeline projects\n<\/li>\n<li>\nThe pipeline guide reviews latest news related to pipeline therapeutics for Geographic Atrophy\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nProcure strategically important competitor information, analysis, and insights to formulate effective R&amp;D strategies\n<\/li>\n<li>\nRecognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage\n<\/li>\n<li>\nFind and recognize significant and varied types of therapeutics under development for Geographic Atrophy\n<\/li>\n<li>\nClassify potential new clients or partners in the target demographic\n<\/li>\n<li>\nDevelop tactical initiatives by understanding the focus areas of leading companies\n<\/li>\n<li>\nPlan mergers and acquisitions meritoriously by identifying key players and it&#8217;s most promising pipeline therapeutics\n<\/li>\n<li>\nFormulate corrective measures for pipeline projects by understanding Geographic Atrophy pipeline depth and focus of Indication therapeutics\n<\/li>\n<li>\nDevelop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope\n<\/li>\n<li>\nAdjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<ul>\n<li>\n<strong>Introduction<\/strong><\/p>\n<ul>\n<li>\nReport Coverage\n<\/li>\n<li>\nIndication &#8211; Overview\n<\/li>\n<li>\nIndication &#8211; Therapeutics Development\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<strong>Pipeline Overview<\/strong><\/p>\n<ul>\n<li>\nPipeline by Companies\n<\/li>\n<li>\nPipeline by Universities\/Institutes\n<\/li>\n<li>\nProducts under Development by Companies\n<\/li>\n<li>\nProducts under Development by Universities\/Institutes\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<strong>Therapeutics Assessment<\/strong><\/p>\n<ul>\n<li>\nAssessment by Target\n<\/li>\n<li>\nAssessment by Mechanism of Action\n<\/li>\n<li>\nAssessment by Route of Administration\n<\/li>\n<li>\nAssessment by Molecule Type\n<\/li>\n<\/ul>\n<\/li>\n<li>\n<strong>Companies Involved in Therapeutics Development<\/strong>\n<\/li>\n<li>\n<strong>Drug Profiles<\/strong>\n<\/li>\n<li>\n<strong>Product Development Milestones<\/strong>\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5583499\/geographic-atrophy-drugs-in-development-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=sj96pd&amp;utm_campaign=1718572+-+Geographic+Atrophy+Drugs+in+Development+Pipeline+Guide+2022&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/b7a6rh<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x70;&#x72;&#101;s&#x73;&#64;r&#x65;&#x73;&#101;a&#x72;&#x63;&#104;a&#x6e;&#100;&#109;&#x61;&#x72;&#107;e&#x74;&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#x73;s&#64;&#x72;&#101;&#x73;e&#97;&#x72;&#99;&#x68;a&#x6e;&#x64;&#109;&#x61;r&#x6b;e&#116;&#x73;&#46;&#x63;o&#109;<\/a>\n<\/p>\n<p>\nFor E.S.T. Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides comprehensive information on the therapeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45491","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides comprehensive information on the therapeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-24T16:01:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Geographic Atrophy Drugs in Development Pipeline Guide 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-24T16:01:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/\"},\"wordCount\":556,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005373\\\/en\\\/1496632\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/\",\"name\":\"Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005373\\\/en\\\/1496632\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-24T16:01:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005373\\\/en\\\/1496632\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005373\\\/en\\\/1496632\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Geographic Atrophy Drugs in Development Pipeline Guide 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides comprehensive information on the therapeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-24T16:01:29+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-24T16:01:29+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/"},"wordCount":556,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/","name":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg","datePublished":"2022-06-24T16:01:29+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220624005373\/en\/1496632\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/geographic-atrophy-drugs-in-development-pipeline-guide-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Geographic Atrophy Drugs in Development Pipeline Guide 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45491"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45491\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}